Literature DB >> 11749388

Chemical inhibitors of protein kinases.

A J Bridges1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11749388     DOI： 10.1021/cr000250y

Source DB:  PubMed          Journal:  Chem Rev        ISSN： 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  28 in total

1.  Asp746 to glycine change may have a greater influence than Cys751 to serine change in accounting for ligand selectivity between EGFR and HER-2 at the ATP site.

Authors:  Shantaram A Kamath; John K Buolamwini
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

2.  Detection of protein tyrosine-kinase (PTK) gene expression pattern in normal and malignant T lymphocytes by combined PTK-specific polymerase chain reaction and parallel denaturing gradient gel electrophoresis.

Authors:  Zhi-Yong Wang; Qian Zhang; John Wilson; Mariusz Z Ratajczak; Mariusz A Wasik
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

3.  The contribution of a 2-amino group on receptor tyrosine kinase inhibition and antiangiogenic activity in 4-anilinosubstituted pyrrolo[2,3-d]pyrimidines.

Authors:  Aleem Gangjee; Ojas A Namjoshi; Michael A Ihnat; Aaron Buchanan
Journal:  Bioorg Med Chem Lett       Date:  2010-03-24       Impact factor: 2.823

4.  Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.

Authors:  Stanley F Barnett; Deborah Defeo-Jones; Sheng Fu; Paula J Hancock; Kathleen M Haskell; Raymond E Jones; Jason A Kahana; Astrid M Kral; Karen Leander; Ling L Lee; John Malinowski; Elizabeth M McAvoy; Debbie D Nahas; Ronald G Robinson; Hans E Huber
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

5.  Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530.

Authors:  Tim P Green; Mike Fennell; Robin Whittaker; Jon Curwen; Vivien Jacobs; Jack Allen; Armelle Logie; Judith Hargreaves; D Mark Hickinson; Robert W Wilkinson; Paul Elvin; Brigitte Boyer; Neil Carragher; Patrick A Plé; Alun Bermingham; Geoffrey A Holdgate; Walter H J Ward; Laurent F Hennequin; Barry R Davies; Gerard F Costello
Journal:  Mol Oncol       Date:  2009-02-07       Impact factor: 6.603

6.  Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds.

Authors:  Harshani R Lawrence; Roberta Pireddu; Liwei Chen; Yunting Luo; Shen-Shu Sung; Ann Marie Szymanski; M L Richard Yip; Wayne C Guida; Saïd M Sebti; Jie Wu; Nicholas J Lawrence
Journal:  J Med Chem       Date:  2008-08-05       Impact factor: 7.446

Review 7.  Reactivity and biological activity of the marine sesquiterpene hydroquinone avarol and related compounds from sponges of the order Dictyoceratida.

Authors:  Dusan Sladić; Miroslav J Gasić
Journal:  Molecules       Date:  2006-01-31       Impact factor: 4.411

8.  Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5.

Authors:  Andrew S Felts; Sam A Saleh; Uyen Le; Alice L Rodriguez; C David Weaver; P Jeffrey Conn; Craig W Lindsley; Kyle A Emmitte
Journal:  Bioorg Med Chem Lett       Date:  2009-10-09       Impact factor: 2.823

9.  Extremely tight binding of a ruthenium complex to glycogen synthase kinase 3.

Authors:  G Ekin Atilla-Gokcumen; Nicholas Pagano; Craig Streu; Jasna Maksimoska; Panagis Filippakopoulos; Stefan Knapp; Eric Meggers
Journal:  Chembiochem       Date:  2008-12-15       Impact factor: 3.164

Review 10.  Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition.

Authors:  Sébastien Deslandes; Stefan Chassaing; Evelyne Delfourne
Journal:  Mar Drugs       Date:  2009-12-01       Impact factor: 5.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.